Corbus Pharmaceuticals Holdings, Inc. (CRBP) vs LENZ Therapeutics, Inc. (LENZ)
A side-by-side comparison of Corbus Pharmaceuticals Holdings, Inc. and LENZ Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRBP
Corbus Pharmaceuticals Holdings, Inc.
$5.86HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
LENZ
LENZ Therapeutics, Inc.
$3.80HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
Total return — CRBP vs LENZ
growth of $100 · dividends reinvested · last 5yCRBP -90.6% (-37.7%/yr)LENZ -91.4% (-38.7%/yr)CRBP compounded faster over this window
CRBP LENZ
CRBP vs LENZ: by the numbers
- •LENZ is the larger company ($119M vs $109M market cap).
- •Both run net losses; CRBP's is the smaller (0.00% vs -586.74% net margin).
Metrics side by side
Valuation
| Metric | CRBP | LENZ |
|---|---|---|
| P/S ratio | N/A | 5.54 |
| P/B ratio | 1.06 | 0.54 |
Profitability
| Metric | CRBP | LENZ |
|---|---|---|
| Gross margin | 0.00% | 90.14% |
| Operating margin | 0.00% | -477.46% |
| Net margin | 0.00% | -586.74% |
| ROE | -99.67% | -57.47% |
| ROIC | -101.30% | -61.84% |
Growth (annualized)
| Metric | CRBP | LENZ |
|---|---|---|
| Total return CAGR (5Y) | -28.32% | -35.49% |
Frequently asked
- How have CRBP and LENZ total returns compared?
- Over the past 5 years, CRBP delivered -28.32% and LENZ delivered -35.49% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.